- Home
- ROIV vs APPF Comparison
ROIV vs APPF Comparison
Compare ROIV & APPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- APPF
- Stock Information
- Founded
- ROIV 2014
- APPF 2006
- Country
- ROIV United Kingdom
- APPF United States
- Employees
- ROIV N/A
- APPF N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- APPF Computer Software: Prepackaged Software
- Sector
- ROIV Health Care
- APPF Technology
- Exchange
- ROIV Nasdaq
- APPF Nasdaq
- Market Cap
- ROIV 8.8B
- APPF 9.4B
- IPO Year
- ROIV N/A
- APPF 2015
- Fundamental
- Price
- ROIV $11.57
- APPF $251.79
- Analyst Decision
- ROIV Strong Buy
- APPF Buy
- Analyst Count
- ROIV 8
- APPF 6
- Target Price
- ROIV $17.93
- APPF $270.67
- AVG Volume (30 Days)
- ROIV 5.3M
- APPF 198.0K
- Earning Date
- ROIV 02-11-2025
- APPF 01-23-2025
- Dividend Yield
- ROIV N/A
- APPF N/A
- EPS Growth
- ROIV N/A
- APPF N/A
- EPS
- ROIV 5.89
- APPF 3.53
- Revenue
- ROIV $129,128,999.00
- APPF $762,368,000.00
- Revenue This Year
- ROIV $15.98
- APPF $29.81
- Revenue Next Year
- ROIV N/A
- APPF $17.76
- P/E Ratio
- ROIV $2.06
- APPF $71.31
- Revenue Growth
- ROIV 145.68
- APPF 33.12
- 52 Week Low
- ROIV $9.69
- APPF $164.29
- 52 Week High
- ROIV $13.06
- APPF $274.56
- Technical
- Relative Strength Index (RSI)
- ROIV 41.56
- APPF 51.79
- Support Level
- ROIV $11.72
- APPF $255.64
- Resistance Level
- ROIV $12.22
- APPF $264.98
- Average True Range (ATR)
- ROIV 0.30
- APPF 8.32
- MACD
- ROIV -0.09
- APPF -2.38
- Stochastic Oscillator
- ROIV 15.24
- APPF 24.55
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About APPF AppFolio Inc.
AppFolio Inc is a provider of cloud-based software solutions for real estate industry. Its property management software provides property managers with an end-to-end solution to their business needs. Its products include cloud-based property management software (Appfolio Property Manager). It also offers value-added services, such as screening, risk mitigation and electronic payment services. The business activity of the firm predominantly functions through the United States and it generates revenue in the form of subscription fees.